IBEX Wealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$328K Buy
+10,945
New +$361K 0.09% 98
2022
Q3
Sell
-209,118
Closed -$6.7M 149
2022
Q2
$6.7M Sell
209,118
-7,607
-4% -$280K 1.54% 17
2022
Q1
$6.82M Buy
216,725
+15,869
+8% +$496K 1.31% 24
2021
Q4
$6.74M Buy
200,856
+11,998
+6% +$374K 1.19% 23
2021
Q3
$5.49M Buy
188,858
+6,659
+4% +$216K 1.06% 27
2021
Q2
$6.34M Buy
182,199
+8,025
+5% +$266K 1.27% 17
2021
Q1
$4.86M Buy
+174,174
New +$4.63M 1.2% 26

Other funds holding CC

IBEX Wealth Advisors's CC Position: Q1 2023 in Review

IBEX Wealth Advisors opened a new position in Chemours (CC) in Q1 2023: 10,945 shares worth $328K. The stake represents 0.09% of the portfolio and ranks #98 among its holdings. This is a return to the name: IBEX Wealth Advisors previously reported a position in CC as recently as Q2 2022.

IBEX Wealth Advisors first reported a position in CC in Q1 2021 and has held it in 7 quarters since. The position peaked at $6.82M in Q1 2022. 487 funds tracked by Wall St. Rank hold CC as of Q1 2023.

  • IBEX Wealth Advisors held 10,945 shares of Chemours worth $328K as of Q1 2023.
  • Chemours was a new IBEX Wealth Advisors position in Q1 2023.
  • Chemours made up 0.09% of IBEX Wealth Advisors's portfolio in Q1 2023, its #98 holding.
  • IBEX Wealth Advisors first reported a position in Chemours in Q1 2021 and has held it in 7 quarters since.
  • IBEX Wealth Advisors's Chemours position peaked at $6.82M in Q1 2022.
  • 487 funds tracked by Wall St. Rank held Chemours as of Q1 2023.

Based on IBEX Wealth Advisors's 13F filing for Q1 2023, filed 15 May 2023.